Trivalent metal complex geometry of the substrate governs cathepsin B enzymatic cleavage rate.

The lysosomal protease cathepsin B recognizes defined, short peptide sequences, providing means for effective, targeted drug release. Here, we show that the introduction of a coordination complex adjacent to the cleavage sequence allows us to tune enzymatic cleavage rate by varying the complexed, trivalent metal ion.

[1]  A. Casini,et al.  Design Strategies and Medicinal Applications of Metal-Peptidic Bioconjugates. , 2020, Bioconjugate chemistry.

[2]  E. Boros,et al.  Site-specific 89Zr and 111In-radiolabeling and in vivo evaluation of glycan-free antibodies by azide-alkyne cycloaddition with a non-natural amino acid. , 2020, Bioconjugate chemistry.

[3]  D. Kovacs,et al.  Eu(III) and Tb(III) Complexes of Octa- and Nonadentate Macrocyclic Ligands Carrying Azide, Alkyne, and Ester Reactive Groups. , 2019, Inorganic chemistry.

[4]  J. Nicolas,et al.  Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases. , 2019, Advanced drug delivery reviews.

[5]  D. Spring,et al.  Cleavable linkers in antibody-drug conjugates. , 2019, Chemical Society reviews.

[6]  D. Kovacs,et al.  Highly luminescent lanthanide complexes sensitised by tertiary amide-linked carbostyril antennae. , 2018, Dalton transactions.

[7]  Cecile Chalouni,et al.  FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates. , 2018, Bioconjugate chemistry.

[8]  B. Vollmar,et al.  Immolation of p-Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody-Drug Conjugates with Phenol-Containing Payloads. , 2018, Bioconjugate chemistry.

[9]  D. Neri,et al.  Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates. , 2017, Bioconjugate chemistry.

[10]  D. Neri,et al.  Linker stability influences the anti‐tumor activity of acetazolamide‐drug conjugates for the therapy of renal cell carcinoma , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. Hartley,et al.  Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer Payload. , 2016, ACS medicinal chemistry letters.

[12]  Amanda C. Freise,et al.  In vivo imaging with antibodies and engineered fragments. , 2015, Molecular immunology.

[13]  E. Rosenthal,et al.  Antibody-based imaging strategies for cancer , 2014, Cancer and Metastasis Reviews.

[14]  C. J. Murray,et al.  Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system. , 2014, Bioconjugate chemistry.

[15]  Li-Yi Zhang,et al.  Zn2+ responsive bimodal magnetic resonance imaging and fluorescent imaging probe based on a gadolinium(III) complex. , 2012, Inorganic chemistry.

[16]  S. Batra,et al.  Recent trends in antibody-based oncologic imaging. , 2012, Cancer letters.

[17]  Alain Wagner,et al.  Cleavable linkers in chemical biology. , 2012, Bioorganic & medicinal chemistry.

[18]  Eva M. Sevick-Muraca,et al.  Dual-Labeling Strategies for Nuclear and Fluorescence Molecular Imaging: A Review and Analysis , 2011, Molecular Imaging and Biology.

[19]  A. Kenwright,et al.  Lanthanide complexes of DOTA monoamide derivatives bearing an isophthalate pendent arm. , 2011, Dalton transactions.

[20]  Flora L Thorp-Greenwood,et al.  Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents. , 2011, Dalton transactions.

[21]  É. Tóth,et al.  Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. , 2010, Inorganic chemistry.

[22]  J. Reubi,et al.  Biodistribution of two octreotate analogs radiolabeled with indium and yttrium in rats. , 2010, Anticancer research.

[23]  Shuang Liu,et al.  Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions. , 2007, Inorganic chemistry.

[24]  P. Fanwick,et al.  Synthesis, characterization, and X-ray crystal structure of In(DOTA-AA) (AA = p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates. , 2003, Inorganic chemistry.

[25]  M. Botta,et al.  Structural variations across the lanthanide series of macrocyclic DOTA complexes: insights into the design of contrast agents for magnetic resonance imaging. , 2003, Inorganic chemistry.

[26]  Shuang Liu,et al.  Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates. , 2002, Bioconjugate chemistry.

[27]  P. Trail,et al.  Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity. , 2002, Bioconjugate chemistry.

[28]  M. Hennig,et al.  Radiometal‐Labelled Macrocyclic Chelator‐Derivatised Somatostatin Analogue with Superb Tumour‐Targeting Properties and Potential for Receptor‐Mediated Internal Radiotherapy , 1999 .

[29]  C. Meares,et al.  Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library. , 1998, Bioconjugate chemistry.

[30]  M. Botta,et al.  Conformational and Coordination Equilibria on DOTA Complexes of Lanthanide Metal Ions in Aqueous Solution Studied by (1)H-NMR Spectroscopy. , 1997, Inorganic chemistry.

[31]  Maurizio Grandi,et al.  Synthesis, characterization, and 1/T1 NMRD profiles of gadolinium(III) complexes of monoamide derivatives of DOTA-like ligands. X-ray structure of the 10-[2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-1-[(phenylmethoxy)methyl]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-gadolinium( , 1992 .

[32]  B. Morgan,et al.  Rapid, continuous solution-phase peptide synthesis: Application to peptides of pharmaceutical interest , 2003 .

[33]  T. Kaden,et al.  Synthesis and X-ray structural characterisation of seven co-ordinate macrocyclic In3+ complexes with relevance to radiopharmaceutical applications , 1989 .